A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma

Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) significantly improve the outcomes of patients with advanced clear cell renal cell carcinoma (ccRCC); however, high-grade toxicities can occur, particularly during combination therapy. Herein, we report a patient with advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Gourari, Karim, Catherine, Julien, Garaud, Soizic, Kerger, Joseph, Lepida, Antonia, Georgala, Aspasia, Lebrun, Fabienne, Gomez Galdon, Maria, Gil, Thierry, Willard-Gallo, Karen, Langouo Fontsa, Mireille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871391/
https://www.ncbi.nlm.nih.gov/pubmed/35204627
http://dx.doi.org/10.3390/diagnostics12020539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871391/
https://www.ncbi.nlm.nih.gov/pubmed/35204627
http://dx.doi.org/10.3390/diagnostics12020539

Ejemplares similares